Synthesis, Characterization, and Anti-Cancer Activity of Some New N′-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives
作者:Ayman El-Faham、Muhammad Farooq、Sherine Khattab、Nael Abutaha、Mohammad Wadaan、Hazem Ghabbour、Hoong-Kun Fun
DOI:10.3390/molecules200814638
日期:——
Eight novel N′-(2-oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazone derivatives 4a–h were synthesized and fully characterized by IR, NMR (1H-NMR and 13C-NMR), elemental analysis, and X-ray crystallography. The cyto-toxicity and in vitro anti-cancer evaluation of the prepared compounds have been assessed against two different human tumour cell lines including human liver (HepG2) and leukaemia (Jurkat), as well as in normal cell lines derived from human embryonic kidney (HEK293) using MTT assay. The compounds 3e, 3f, 4a, 4c, and 4e revealed promising anti-cancer activities in tested human tumour cells lines (IC50 values between 3 and 7 μM) as compared to the known anti-cancer drug 5-Fluorouracil (IC50 32–50 μM). Among the tested compounds, 4a showed specificity against leukaemia (Jurkat) cells, with an IC50 value of 3.14 μM, but this compound was inactive in liver cancer and normal cell lines.
合成了八种新型的N′-(2-氧吲哚-3-亚基)-2-丙基戊氨基-肼-肼酮衍生物4a–h,并通过红外光谱(IR)、核磁共振(1H-NMR和13C-NMR)、元素分析和X射线晶体学进行了全面表征。对制备的化合物进行了细胞毒性和体外抗癌评估,评估了其对两种不同人类肿瘤细胞系的影响,包括人肝细胞(HepG2)和白血病细胞(Jurkat),以及来自人胚胎肾(HEK293)的正常细胞系,使用MTT法进行测试。化合物3e、3f、4a、4c和4e在测试的人类肿瘤细胞系中显示出有前景的抗癌活性(IC50值在3到7 μM之间),相比已知的抗癌药物5-氟尿嘧啶(IC50值32–50 μM)。在测试的化合物中,4a对白血病(Jurkat)细胞表现出特异性,其IC50值为3.14 μM,但该化合物在肝癌和正常细胞系中无活性。